Back to CI Champlain Investment Partners, LLC
RGEN16 quarters
Position history for CIChamplain Investment Partners, LLC's holdings in REPLIGEN CORP
Yes. Champlain Investment Partners holds 318,955 shares of RGEN (Repligen), worth $43.5M, as of its Q2 2026 13F filing. It reduced the position by 374,900 shares (-54.0%) from Q1 2026. Champlain Investment Partners has held RGEN since Q3 2022, across 16 quarterly 13F filings. RGEN is 1.1% of Champlain Investment Partners' reported 13F portfolio.
Current Value
$43.5M
Current Shares
318,955
Total Value Change
+$2.6M
Total Shares Change
+100,220
Quarter-by-Quarter History
Other major holders of RGEN: BlackRock Finance, Inc., BlackRock, Inc., PRICE T ROWE ASSOCIATES INC /MD/